PAVM - PAVmed Inc.

QQQ $ 605.62 $ 0.00 (0 %)

DIA $ 463.50 $ 0.00 (0 %)

SPY $ 667.50 $ 0.00 (0 %)

TLT $ 90.58 $ 0.00 (0 %)

GLD $ 391.09 $ 0.00 (0 %)

Previous Close

$ 0.5313

Open

$ 0.55

Bid

$ 0.54 x 1,000

Ask

$ 0.55 x 3,012

Day's Range

-- - --

52 Week Range

$ 0.30 - $ 1.25

Volume

490,482

Average Volume

Market Cap

11.65M

Beta (5Y Monthly)

$ 1.70

PE Ratio (TTM)

$ 0.17

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-24-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	03-25-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-14-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	04-06-2022	12-31-2021	10-K
16	11-22-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-17-2021	03-31-2021	10-Q
19	03-15-2021	12-31-2020	10-K
20	11-06-2020	09-30-2020	10-Q
21	08-14-2020	06-30-2020	10-Q
22	05-28-2020	03-31-2020	10-Q
23	04-14-2020	12-31-2019	10-K
24	11-19-2019	09-30-2019	10-Q
25	08-14-2019	06-30-2019	10-Q
26	05-15-2019	03-31-2019	10-Q
27	04-01-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-13-2018	06-30-2018	10-Q
30	05-21-2018	03-31-2018	10-Q
31	03-14-2018	12-31-2017	10-K
32	11-14-2017	09-30-2017	10-Q
33	08-11-2017	06-30-2017	10-Q
34	05-22-2017	03-31-2017	10-Q
35	02-16-2017	12-31-2016	10-K
36	11-10-2016	09-30-2016	10-Q
37	08-12-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	04-11-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Ascendiant Capital Maintains Buy on PAVmed...
10/06/2025 10:02:55

Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and raises the price target from $19 to $20.

Lucid Diagnostics Announces $25M Public Of...
09/10/2025 12:07:15

Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical...

Lucid Diagnostics Reveals Proposed Public ...
09/09/2025 20:02:40

NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a comm...

PAVmed Announces It Has Signed A Non-Bindi...
08/26/2025 12:08:48

Newly-formed PAVmed subsidiary to license endoscopic imaging technology designed to identify and facilitate ablative treatment ...

PAVmed Q2 Adj. EPS $(0.05) Beats $(0.13) E...
08/14/2025 12:01:57

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61....

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

Lucid Diagnostics, a PAVmed Subsidiary, Ne...
07/16/2025 11:35:15

Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical ...

Ascendiant Capital Maintains Buy on PAVmed...
06/06/2025 10:29:24

Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the price target from $19.5 to $19.

PAVmed Subsidiary, Veris Health, Enters In...
06/03/2025 12:36:37

PAVmed Q1 Adj. EPS $(0.07) Beats $(0.13) E...
05/15/2025 12:02:18

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.13) by 46....

Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

PAVmed's Earnings: A Preview
05/14/2025 19:02:56

Ascendiant Capital Maintains Buy on PAVmed...
04/21/2025 10:16:32

Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and raises the price target from $19 to $19.5.

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
03/31/2025 12:05:38

PAVmed Q4 2024 Adj EPS $(0.06) Beats $(0.5...
03/25/2025 12:03:12

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.57) by 89....

Earnings Scheduled For March 25, 2025
03/25/2025 08:32:09

Lucid Diagnostics Announced NCCN Guideline...
03/20/2025 12:35:52

Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, ...

Lucid Diagnostics' ENVET-BE Clinical Utili...
03/18/2025 12:34:50

Study confirms clinical utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive ...

Lucid Diagnostics, PAVmed Reveal Positive ...
03/13/2025 11:41:37

Regional Blue Cross Blue Shield plan will cover non-invasive screening of esophageal precancer and cancer.

Lucid Diagnostics Announces $15.3M Registe...
03/04/2025 13:26:22

Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical ...

PAVM PAVmed Inc.

Nasdaq pavmed.com

$ 0.55 $ 0.00 (0 %)

Thursday, 16-Oct-2025 08:50:17 EDT

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Search Symbol

Create a Free Account Sign in to your Account Reset Password

PAVM PAVmed Inc.

Nasdaq pavmed.com

$ 0.55 $ 0.00 (0 %)

Thursday, 16-Oct-2025 08:50:17 EDT

Create a Free Account Sign in to your Account Reset Password

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Add/Delete Symbol to your Portfolio